The past, present, and future of drug rates

Wayne Laun and Chris O'Dell look back at how price transparency legislation has impacted drug reimbursement — and look ahead at what's coming next.

They cover how healthcare providers and manufacturers are leveraging drug rates from price transparency data, and how the recent executive order on drug pricing could shape the future of drug price transparency.